Global Wearable Medical Devices Market Outlook to 2030 Highlights Shift Toward Continuous Chronic Care

Introduction

The global wearable medical devices market for chronic disease management is entering a structurally important phase as healthcare systems increasingly rely on continuous monitoring, decentralised care delivery, and data-driven disease management. According to a new market outlook to 2030, the market was valued at US$42.0–45.0 billion in 2024 and is projected to reach US$90.0–95.0 billion by 2030, supported by sustained adoption across diabetes, cardiovascular, respiratory, and neurological care.

The full analysis is available in the Global Wearable Medical Devices Market Outlook to 2030.

For additional context or discussion, Contact Us.

Market Definition

The global wearable medical devices market for chronic disease management refers to medical-grade, connected devices used for continuous monitoring and long-term management of chronic conditions. Growth is driven by rising disease prevalence, technological improvements in sensors and analytics, and the shift toward home-based and remote care models.

Market Overview

Wearable medical devices were initially designed as diagnostic tools, particularly for glucose and cardiac rhythm monitoring. Over the past decade, advances in biosensors, battery efficiency, wireless connectivity, and software platforms have repositioned these devices as continuous disease management systems. The COVID-19 pandemic further accelerated clinical acceptance of remote patient monitoring and reinforced the shift away from hospital-centric care models.

Chronic diseases now account for more than 70% of global healthcare expenditure, creating sustained demand for scalable monitoring solutions that support early intervention, adherence, and outcome tracking. This structural context underpins the long-term relevance of the global wearable medical devices market for chronic disease management.

To explore how these shifts affect specific care models or geographies, Contact Us.

Market Size and Growth Outlook

Between 2019 and 2024, the market expanded at a compound annual growth rate of approximately 14.5%, reflecting increased penetration of continuous glucose monitoring devices and cardiac wearables. From 2025 to 2030, growth is expected to moderate slightly to a 13.2–13.8% compound annual growth rate, as adoption broadens across respiratory and multi-parameter monitoring use cases.

Home care settings account for more than 55% of total demand, highlighting the central role of decentralised care. Regionally, North America represents approximately 42% of global revenue, followed by Europe at around 28%. Asia-Pacific, at roughly 22%, is the fastest-growing region due to expanding healthcare infrastructure and rising chronic disease prevalence.

Additional regional analysis is available in the Global Wearable Medical Devices Market Outlook to 2030.

Market Segmentation and Trends

Key product segments include:

• Glucose monitoring devices, representing approximately 38–40% of market revenue
• Cardiac monitoring wearables, accounting for roughly one quarter of demand
• Respiratory and neurological wearables, supported by increasing multi-morbidity and ageing populations

Technology trends include the growing integration of artificial intelligence-enabled analytics, improved interoperability with electronic health record systems, and convergence between consumer health wearables and regulated medical devices.

For deeper segmentation insights, Contact Us.

Competitive and Regulatory Landscape

The market is moderately concentrated, with leading players accounting for approximately 55–60% of global revenue. Competitive differentiation is primarily based on device accuracy, data integration capabilities, analytics platforms, and alignment with reimbursement frameworks.

Regulatory compliance remains a defining factor, with manufacturers navigating FDA clearance pathways, the EU Medical Device Regulation, ISO 13485 quality standards, and data protection requirements such as HIPAA and GDPR.

Future Outlook

By 2030, wearable medical devices are expected to play a central role in closed-loop and outcome-oriented chronic disease management systems. Stakeholders are increasingly focused on interoperability, payer alignment, and region-specific deployment strategies to support sustainable adoption.

Decision-makers seeking deeper insights into the global wearable medical devices market for chronic disease management can explore related digital health insights or Contact Us to discuss how these findings apply to specific strategic, investment, or operational questions.